Thumbnail
Access Restriction
Open

Author Burgmans, Mark C. ♦ Leede, Eleonora M. de ♦ Martini, Christian H. ♦ Kapiteijn, Ellen ♦ Vahrmeijer, Alexander L. ♦ Erkel, Arian R. van
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword RADIOLOGY AND NUCLEAR MEDICINE ♦ ABLATION ♦ CHEMOTHERAPY ♦ LIVER ♦ NEOPLASMS ♦ PATIENTS ♦ RADIOEMBOLIZATION ♦ REVIEWS ♦ SURGERY
Abstract Liver malignancies are a major burden of disease worldwide. The long-term prognosis for patients with unresectable tumors remains poor, despite advances in systemic chemotherapy, targeted agents, and minimally invasive therapies such as ablation, chemoembolization, and radioembolization. Thus, the demand for new and better treatments for malignant liver tumors remains high. Surgical isolated hepatic perfusion (IHP) has been shown to be effective in patients with various hepatic malignancies, but is complex, associated with high complication rates and not repeatable. Percutaneous isolated liver perfusion (PHP) is a novel minimally invasive, repeatable, and safer alternative to IHP. PHP is rapidly gaining interest and the number of procedures performed in Europe now exceeds 200. This review discusses the indications, technique and patient management of PHP and provides an overview of the available data.
ISSN 01741551
Educational Use Research
Learning Resource Type Article
Publisher Date 2016-06-15
Publisher Place United States
Journal Cardiovascular and Interventional Radiology
Volume Number 39
Issue Number 6


Open content in new tab

   Open content in new tab